Prevalence and Type Distribution of Human Papillomavirus Infection Using the INNo-Lipa Assay, Kerman, Southeast Iran

  • Published : 2013.09.30


The human papilloma virus (HPV) causes skin and mucous membrane infections. It crosses from one person to another by skin-to-skin contact, such as sexual contact. There are more than 100 types of HPV that can influence different parts of the body. Some types of HPV can cause cancer (such as cervical or anal cancer) and others can cause warts (such as genital or plantar warts). HPV infection is one of the most common sexually transmitted infections (STIs) in Iran and around the world. Considerable molecular evidence suggests a role for human papilloma virus (HPV) in the pathogenesis of carcinoma. Epidemiological studies on human papilloma viruses (HPVs) infections in general population are critical for the performing of health policy guidelines for developing the strategies to hinder the primary and secondary different cancer. In different parts of Iran, there is a lack of population-based studies to determine the prevalence of HPV in the general population. The aim of this population-based study was therefore to report the prevalence ratse of HPV types among Iranian patients. To study the risk of human papilloma virus (HPV) infection, we managed a retrospective study in Kerman province, southeast of Iran. For this purpose, 410 patients tested for the presence of HPV DNA using PCR and INNo-Lipa assays. HPV DNA was detected in 108 out of 410 patients (26.34%), while it was not detected in any of the control group samples. Patients included 23 (21.1%) males and 86 (78.8%) females. HPV type 6 was the most common (49%) followed by HPV type 16 (10.1%), and also HPV type11 (9.2%). The prevalence of HPV in Iran is comparable to those reported in other regions of the world. In a similar manner, it seems that HPV types 6, 16 and11 are the most common types in Kerman. Additional studies on larger group of patients, particularly in those with pre-invasive forms of disease, are needed to explain the roles of different HPV types in this location of Iran.


  1. Aljunid S, Zafar A, Saperi S, et al (2010). Burden of disease associated with cervical cancer in malaysia and potential costs and consequences of HPV vaccination. Asian Pac J Cancer Prev, 11, 1551-9.
  2. Best S, Niparko K, Pai S (2012). Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. Otolaryngol Clin North Am, 45, 807-22.
  3. Alsaad M, Shamsuddin K, Fadzil F (2012). Knowledge towards HPV infection and HPV vaccines among Syrian mothers. Asian Pac J Cancer Prev, 13, 879-83.
  4. Babiker A, Eltom F, Abdalaziz A, et al (2013). Screening for high risk human papilloma virus subtypes, among Sudanese patients with oral lesions. Int J Clin Exp Med, 6, 275-81.
  5. Barbieri D, Nocera M, Gallinella G, et al (2012). Comparison of HPV sign genotyping test with INNO-LiPA HPV genotyping extra assay on histologic and cytologic cervical specimens. Diagn Microbiol Infect Dis, 74, 43-8.
  6. Chimeddorj B, Pak C, Damdin A, et al (2008). Distribution of HPV-16 intratypic variants among women with cervical intraepithelial neoplasia and invasive cervical cancer in Mongolia. Asian Pac J Cancer Prev, 9, 563-8.
  7. Chinchai T, Chansaenroj J, Junyangdikul P, et al (2011). Comparison between direct sequencing and INNO-LiPA methods for HPV detection and genotyping in Thai Women. Asian Pac J Cancer Prev, 12, 989-94.
  8. Ciarrocca K, Jackson L, Rossi S (2013). Human papillomavirus: the fundamentals of HPV for oral health care providers. J Calif Dent Assoc, 41, 349-55.
  9. Diamantopoulou S, Spathis A, Chranioti A, et al (2013). Liquid based cytology and HPV DNA testing in a Greek population compared to colposcopy and histology. Clin Exp Obstet Gynecol, 40, 131-6.
  10. Didelot-Rousseau M, Courgnaud V, Nagot N, et al (2006). Comparison of INNO-LiPA HPV genotyping v2 with PCR product subcloning and sequencing for identification of genital human papillomavirus genotypes in African women. J Virol Methods, 135, 181-5.
  11. Grce M, Grahovac B, Rukavina T, et al (2007). HPV testing for cervical cancer screening in Croatia. Coll Antropol, 31, 67-71.
  12. Galan-Sanchez F, Hernandez M, Hernandez D, et al (2011). Performance of the new INNO-LiPA HPV extra to genotype human papillomavirus in cervical cell specimens. Acta Cytol, 55, 341-3.
  13. Gold M, Thomas M, Huh W, et al (2013). High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test. J Low Genit Tract Dis, 17, 51-7.
  14. Grace J, Narendhirakannan R (2011). Detection and genotyping of high-risk HPV and evaluation of anti-oxidant status in cervical carcinoma patients in Tamil Nadu State, India. Asian Pac J Cancer Prev, 12, 2689-95.
  15. Huang Y, Lin M, Luo Z, et al (2013). Low prevalence of HPV in male sexual partners of HR-HPV infected females and low concordance of viral types in couples in Eastern Guangdong. Asian Pac J Cancer Prev, 14, 1755-60.
  16. Jaberipour M, Samsami A, Sahraiian F, et al (2011). Elevation of HPV-18 and HPV-16 DNA in the plasma of patients with advanced cervical cancer. Asian Pac J Cancer Prev, 12, 163-7.
  17. Karimi M, Behtash N, Chiti Z, et al (2009). Cervical cancer and HPV vaccines in developing countries. Asian Pac J Cancer Prev, 10, 969-74.
  18. Micalessi M, Boulet G, Vorsters A, et al (2013). A real-time PCR approach based on SPF10 primers and the INNO-LiPA HPV genotyping extra assay for the detection and typing of human papillomavirus. J Virol Methods, 187, 166-71.
  19. Mohabatkar H (2007). Prediction of epitopes and structural properties of Iranian HPV-16 E6 by bioinformatics methods. Asian Pac J Cancer Prev, 8, 602-6.
  20. Safaei A, Khanlari M, Momtahen M, et al (2010). Prevalence of high risk human papillomavirus types 16 and 18 in healthy women with cytologically negative pap smear in Iran. Indian J Pathol Microbiol, 53, 681-5.
  21. Nirchio V, Lipsi R, Fusilli S, et al (2008). HPV infection: comparison between morphological studies and molecular biology. Pathologica, 100, 149-55.
  22. Norman I, Hjerpe A, Andersson S (2013). High-risk HPV L1 capsid protein as a marker of cervical intraepithelial neoplasia in high-risk HPV positive women with minor cytological abnormalities. Oncol Rep, 30, 695-700.
  23. Palefsky J (2006). Biology of HPV in HIV infection. Adv Dent Res, 19, 99-105.
  24. Samoylova E , Shaikhaiev G, Petrov S, et al (1995). HPV infection in cervical-cancer cases in Russia. Int J Cancer, 61, 337-41.
  25. Shahramian I, Heidari Z, Mahmoudzadeh H, et al (2011). Prevalence of HPV infection and high risk HPV genotypes (16, 18) among monogamous and polygamous women, In Zabol, Iran. Iran J Public Health, 40, 113-21.
  26. Yahyapour Y, Shamsi-Shahrabadi M, Mahmoudi M, et al (2012). High risk and low risk human papillomavirus in esophageal squamous cell carcinoma at Mazandaran northern Iran. Pathol Oncol Res, 21, 54-8.
  27. Young A, Crosby R, Jagger K, et al (2010). HPV vaccine acceptability among women in the philippines. Asian Pac J Cancer Prev, 11, 1781-7.
  28. Zandi K, Eghbali S, Hamkar R, et al (2010). Prevalence of various human papillomavirus genotypes among women who subjected to routine Pap smear test in Bushehr city. Virol J, 7, 65.

Cited by

  1. Development of In-House Multiplex Real Time PCR for Human Papillomavirus Genotyping in Iranian Women with Cervical Cancer and Cervical Intraepithelial Neoplasia vol.15, pp.15, 2014,
  2. Prevalence of Abnormal Anal Cytology in HIV-Infected Women: a Hospital-Based Study vol.15, pp.15, 2014,
  3. Anal Papanicolaou Smear in Women with Abnormal Cytology: a Thai Hospital Experience vol.16, pp.3, 2015,
  4. The Prevalence and Genotype Distribution of Human Papillomavirus in the Genital Tract of Males in Iran vol.8, pp.12, 2015,
  5. The Frequency and Typing of Human Papilloma Virus Among Women with Normal and Abnormal Cytology in Southern Khorasan, Eastern Iran vol.In Press, pp.In Press, 2017,
  6. Cryotherapy versus CO2 laser in the treatment of plantar warts: a randomized controlled trial vol.8, pp.3, 2018,